Determinan Keberhasilan Pengobatan Pasien Tuberkulosis  di Kota Pangkalpinang Tahun 2025

Fitriadi Fitriadi; Rico Januar Sitorus; Taufik Kurrohman; Dedek Sutinbuk; Heru Listiono

doi:10.71094/vkj.v4i1.292

Authors

Fitriadi Program Studi Kesehatan Masyarakat, Universitas Anak Bangsa, Indonesia
Rico Januar Sitorus Program Studi Kesehatan Masyarakat, Universitas Anak Bangsa, Indonesia
Taufik Kurrohman Program Studi Kesehatan Masyarakat, Universitas Anak Bangsa, Indonesia
Dedek Sutinbuk Program Studi Kesehatan Masyarakat, Universitas Anak Bangsa, Indonesia
Heru Listiono Program Studi Kesehatan Masyarakat, Universitas Anak Bangsa, Indonesia

DOI:

https://doi.org/10.71094/vkj.v4i1.292

Keywords:

Tuberculosis, Treatment Success, Hiv Status, Health Facility, Determinants

Abstract

Tuberculosis (TB) remains a significant public health challenge in Indonesia. Treatment success is a crucial benchmark in TB control efforts, influenced by various patient- and health system-related factors. This study aimed to examine the determinants of treatment success among tuberculosis patients in Pangkalpinang City during 2025. This quantitative analytical study employed a cross-sectional design using secondary data from the Tuberculosis Information System (SITB) of the Pangkalpinang City Health Office. The sample consisted of 874 TB patients who met the inclusion criteria, selected via total sampling. Data analysis involved univariate, bivariate (Chi-Square test), and multivariate (logistic regression) methods. The TB treatment success rate was recorded at 90.3%. Bivariate analysis revealed that HIV status was significantly correlated with treatment success (p<0.001), whereas age (p=0.082), gender (p=0.738), and type of health facility (p=0.090) did not show significant associations. Multivariate analysis results indicated that age (POR=1.697; 95%CI=1.046-2.754; p=0.032), HIV status (POR=2.172; 95%CI=1.642-2.872; p<0.001), and type of health facility (POR=2.468; 95%CI=1.443-4.222; p<0.001) were determinants of TB treatment success, with the type of health facility serving as the most dominant predictor of successful treatment outcomes.

Downloads

Download data is not yet available.

References

Adiputra, I. M. S., dkk. (2021). Metodologi penelitian kesehatan. Medan: Yayasan Kita Menulis.

Al-Bari, M. A. A., Peake, N., & Eid, N. (2024). Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges. World Journal of Diabetes, 15(5), 853-866. doi:10.4239/wjd.v15.i5.853

Alimy, R. A., & Ronoatmodjo, S. (2023). Faktor yang berhubungan dengan keberhasilan pengobatan pada pasien TB dewasa di Puskesmas Kecamatan Tapos Kota Depok Tahun 2020-2022 (Analisis Data SITB). Jurnal Cahaya Mandalika, 3(2), 753-764.

Arikunto, S. (2013). Prosedur penelitian: Suatu pendekatan praktik. Jakarta: Rineka Cipta.

Australian Society for HIV, Viral Hepatitis and Sexual Health Medicine. (2024). Management of active tuberculosis. Retrieved from https://hiv.guidelines.org.au/management/mycobacterium-tuberculosis-infection-in-people-with-hiv-infection/management-of-active-tuberculosis/

Creswell, J. W. (2014). Research design: Pendekatan kualitatif, kuantitatif, dan mixed. Yogyakarta: Pustaka Pelajar.

Diah, A. K., Hartati, E., & Handayani, S. (2023). Determinant of successful tuberculosis treatment in Puskesmas. Keluwih: Jurnal Kesehatan dan Kedokteran, 5(1), 7-19. doi:10.24123/kesdok.v5i1.5972

Direktorat Jenderal Pelayanan Kesehatan Kementerian Kesehatan Republik Indonesia. (2020). Petunjuk teknis penggunaan Sistem Informasi Tuberkulosis (SITB). Jakarta: Kementerian Kesehatan RI.

Fitria, Sitorus, R. J., & Flora, R. (2025). Determinants of treatment success for tuberculosis cases in Sumatra, Indonesia. Malahayati International Journal of Nursing and Health Science, 8(1).

Haryono, Rubaya, A. K., & Husein, A. (2021). Pengantar epidemiologi. Sleman: Poltekkes Jogja Press.

Kementerian Kesehatan Republik Indonesia. (2019). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/755/2019 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Jakarta: Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2020a). Pedoman nasional pelayanan kedokteran tata laksana tuberkulosis. Jakarta: Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2020b). Petunjuk teknis penanganan infeksi laten tuberkulosis (ILTB). Jakarta: Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2022). Profil Kesehatan Indonesia 2021. Jakarta: Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2023). Profil Kesehatan Indonesia 2022. Jakarta: Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2025a). Penanganan infeksi laten tuberkulosis (ILTB). Jakarta: Kementerian Kesehatan RI.

Kementerian Kesehatan Republik Indonesia. (2025b). Petunjuk teknis penatalaksanaan tuberkulosis sensitif obat di Indonesia. Jakarta: Kementerian Kesehatan RI.

Khasanah, U. (2024). Gambaran keberhasilan pengobatan tuberkulosis paru di Puskesmas Jatisampurna, Bekasi. Media Publikasi Promosi Kesehatan Indonesia, 7(1), 210-215.

Notoatmodjo, S. (2007). Promosi kesehatan dan ilmu perilaku. Jakarta: Rineka Cipta.

Notoatmodjo, S. (2012). Metodologi penelitian kesehatan. Jakarta: Rineka Cipta.

Perhimpunan Dokter Paru Indonesia. (2021). Tuberkulosis: Pedoman diagnosis dan penatalaksanaan di Indonesia. Jakarta: PDPI.

Perkumpulan Endokrinologi Indonesia. (2021). Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: PB PERKENI. Retrieved from https://pbperkeni.or.id/unduhan

Pulungan, R. M., & Permatasari, P. (2021). Predisposing and enabling factors relationship with successful treatment of pulmonary tuberculosis (TB). Jurnal Kesehatan Prima, 15(1), 57-64. doi:10.32807/jkp.v15i1.634

Putra, G. W., & Pradnyani, P. E. (2022). Determinan keberhasilan pengobatan pasien tuberkulosis di Kota Denpasar Tahun 2021. Indonesian of Health Information Management Journal (INOHIM), 10(2), 66-72. doi:10.47007/inohim.v10i2.429

Rahmi, U. (2020). Analisis faktor kepatuhan berobat penderita tuberculosis paru di Bandung. Wiraraja Medika: Jurnal Kesehatan, 10(1), 23-28. doi:10.24929/fik.v10i1.930

Saefina, I. D., & Adisasmita, A. C. (2025). Gambaran keberhasilan pengobatan tuberkulosis pasien sensitif obat (SO) di Puskesmas Pondok Kacang Timur Tahun 2020-2023. Syntax Literate: Jurnal Ilmiah Indonesia, 10(6), 5796-5806.

Salsabila, A., & Ronoatmodjo, S. (2024). Studi di DKI Jakarta: Peran karakteristik pasien dewasa dengan keberhasilan pengobatan tuberkulosis paru. The Indonesian Journal of Infectious Disease, 10(2), 89-99.

Shilongo, E. (2022). Treatment outcomes and associated factors in TB/HIV-coinfected patients in Namibia (Doctoral dissertation). Retrieved from https://scholarworks.waldenu.edu/dissertations/13108/

Sitorus, R. J. (2023). Buku ajar dasar epidemiologi. Banyumas: Wawasan Ilmu.

Tiwari, P., & Tiwari, S. (2009). Epidemiology made easy (1st ed.). New Delhi: Jaypee Brothers Medical Publishers.

World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization.

World Health Organization. (2022). Framework for collaborative action on tuberculosis and comorbidities. Geneva: World Health Organization.

World Health Organization. (2024). WHO consolidated guidelines on tuberculosis: Mdule 3. Diagnosis—Rapid diagnostics for tuberculosis detection (3rd ed.). Geneva: World Health Organization. Retrieved from https://www.who.int/publications/i/item/9789240094529